ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CVSG Cvs Group Plc

1,008.00
-2.00 (-0.20%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.20% 1,008.00 1,008.00 1,014.00 1,014.00 994.00 1,002.00 125,197 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 608.3M 41.9M 0.5843 17.35 727.17M

CVS Group plc Directorate Change

18/06/2024 1:35pm

RNS Regulatory News


RNS Number : 9147S
CVS Group plc
18 June 2024
 

For immediate release                                                                                    18 June 2024

 

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

Directorate change

 

CVS, the UK listed veterinary group and a leading provider of veterinary services announces that Ben Jacklin, Executive Director, has resigned.  Ben's managerial and operational responsibilities, including the provision of clinical guidance to the Board, have been assumed by other senior members of the Group.  

 

David Wilton, Chair, commented:

"On behalf of the board and everyone at CVS, I would like to thank Ben for his significant contribution to CVS and wish him every success in the future."

 

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.  The person responsible for making this announcement on behalf of the Group is Richard Fairman, CEO.

 

 

CVS Group plc                                                                                                    via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)                          +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

  Berenberg (Joint Broker)                                                                      +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR)                                                                                             

Ginny Pulbrook                                                                                       +44 (0)7961 315 138

Geoffrey Pelham-Lane                                                                              +44 (0)7733 124 226

 

   About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group operates c.460 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices) and an online retail business ("Animed Direct").

 

The Group employs c.9,000 personnel, including c.2,400 veterinary surgeons and c.3,400 nurses.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWOURSSUNAAR

1 Year Cvs Chart

1 Year Cvs Chart

1 Month Cvs Chart

1 Month Cvs Chart

Your Recent History

Delayed Upgrade Clock